Bank Of America Corp Neovasc Inc Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$6.5 - $16.05 $1,300 - $3,210
-200 Reduced 6.89%
2,701 $42,000
Q3 2022

Nov 14, 2022
SELL
$5.95 - $7.93 $4,218 - $5,622
-709 Reduced 19.64%
2,901 $20,000
Q2 2022

Aug 12, 2022
BUY
$4.9 - $10.75 $17,689 - $38,807
3,610 New
3,610 $21,000

About NEOVASC INC

NVCN Quotes by TradingView
  • Ticker NVCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 2,743,140
  • Description
  • Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly kn...
More about NVCN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email